ConductScience.org, home

Paper497405

Tolerance of hemopoiesis for repeated cytotoxic drug therapy.

Lohrmann HP. Blut, 1979. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Tolerance of hemopoiesis for repeated cytotoxic drug therapy. Papers, record 497405. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/497405

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tolerance of hemopoiesis for repeated cytotoxic drug therapy.
PubMed
Journal
Blut
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lohrmann HPH P

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
HematopoiesisMajor topic
Animals
Busulfan
Carmustine
Hematopoietic Stem Cells
Humans

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1105227Acute leukemia following prolonged cytotoxic agent therapy.Medicine (Baltimore)1979https://conductscience.org/library/papers/105227PubMed
2555689Nature of the hemopoietic stem cell compartment and its proliferative potential.Blood Cells1979https://conductscience.org/library/papers/555689PubMed
3406560Acute leukemia after alkylating-agent therapy of ovarian cancer.N Engl J Med1977https://conductscience.org/library/papers/406560PubMed
4766582Toxicity of antineoplastic agents in man, chromosomal aberrations antifertility effects, congenital malformations, and carcinogenic potential.Adv Cancer Res1975https://conductscience.org/library/papers/766582PubMed
51003558Screening of cytotoxic drugs for residual bone marrow damage.J Natl Cancer Inst1976https://conductscience.org/library/papers/1003558PubMed
61259934Residual marrow damage: possible explanation for idiosyncrasy to chloramphenicol.Br J Haematol1976https://conductscience.org/library/papers/1259934PubMed
75059646Granulopoiesis during myleran-induced suppression of transplantable hen atopoietic stem cells.Blood1972https://conductscience.org/library/papers/5059646PubMed
8747780The relationship between the spleen colony-forming cell and the haemopoietic stem cell.Blood Cells1978https://conductscience.org/library/papers/747780PubMed
9761226Sensitivity of human granulopoiesis in vitro to adriamycin before and after exposure in vivo.Cancer Res1979https://conductscience.org/library/papers/761226PubMed
10286640Acute leukemia as a complication of long-term treatment of advanced breast cancer.Cancer Treat Rep1979https://conductscience.org/library/papers/286640PubMed
11235339A primary stem cell lesion in experimental chronic hypoplastic marrow failure.Blood1975https://conductscience.org/library/papers/235339PubMed
12210931Acute and long-term cytogenetic effects of childhood cancer chemotherapy and radiotherapy.Cancer Res1978https://conductscience.org/library/papers/210931PubMed
134462526Haemopoietic precursor cells in experimental hypoplastic marrow failure.Aust J Exp Biol Med Sci1974https://conductscience.org/library/papers/4462526PubMed
144907256Recovery of proliferative capacity of agar colony-forming cells and spleen colony-forming cells following ionizing radiation or vinblastine.J Cell Physiol1970https://conductscience.org/library/papers/4907256PubMed
154428012Effect of repeated doses of x-rays or 14 MeV neutrons on mouse bone marrow.Radiat Res1974https://conductscience.org/library/papers/4428012PubMed
165640790Hematological recovery in the mouse following single doses of gamma radiation and cyclophosphamide.Radiat Res1968https://conductscience.org/library/papers/5640790PubMed
17758963Reaction of human granulopoiesis to high-dose cyclophosphamide therapy.Blut1979https://conductscience.org/library/papers/758963PubMed
18445330Therapy-related leukemia: a panmyelosis.Cancer1979https://conductscience.org/library/papers/445330PubMed
19984038Effects of single and combined chemotherapeutic agents on hemopoietic stem cells in mice.Am J Hematol1976https://conductscience.org/library/papers/984038PubMed
204834516An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan.Blood1974https://conductscience.org/library/papers/4834516PubMed

See all 38 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/497405

GET https://conductscience.org/api/papers/v1/497405/references?page=2